Overpaying for GLP-1 medications is extremely common, with a new data analysis of 102,166 drugs showing that 92% of those prescriptions could have been filled at a lower price.
The DoseSpot analysis estimated that if the prescriptions had been filled at the lower price, patients could have saved a combined $10.2 million in their medications in the first quarter of this year alone.
